Endo International (ENDP) Tops Q1 EPS by 20c, Guidance Misses Consensus

Endo International (NASDAQ: ENDP) reported Q1 EPS of $0.66, $0.20 better than the analyst estimate of $0.46. Revenue for the quarter came in at $652 million versus the consensus estimate of $631.07 million.

GUIDANCE:

Endo International sees Q2 2022 EPS of ($0.17)-($0.15), versus the consensus of $0.48. Endo International sees Q2 2022 revenue of $550-525 million, versus the consensus of $655.6 million.

For earnings history and earnings-related data on Endo International (ENDP) click here.

You May Also Be Interested In

• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• BetterLife Pharma names Charles Duncan as director and audit chair
• Femcare acquires UK harm reduction firm Orion for £3.6M